The data displays the sales growth of the leading brands of analgesic-internal tablets in the U.S. in 2016. The brand Tylenol had a sales growth of 2.8% in the U.S. in 2016 compared to the prior sales year.
Excedrin | 12.8 |
Excedrin Migraine | 10.7 |
Motrin IB | 5 |
Tylenol | 2.8 |
Advil | 0.6 |
Advil PM | -0.2 |
Bayer | -2.7 |
Private label | -2.7 |
Aleve PM | -3.5 |
Aleve | -4.5 |